Navigation Links
In Focus with Martin Sheen Showcasing How Medication is Helping Win the Fight Against Mood Disorders
Date:3/12/2013

Hollywood, CA (PRWEB) March 12, 2013

The producers of In Focus with Martin Sheen are pleased to announce a new report showcasing how people battling mood disorders are receiving new hope through advanced medications.

In Focus Martin Sheen PBS is an independently produced television series airing in markets around the country on public television. The program is hosted by the legendary Martin Sheen, who is about to embark on his second half-century in American entertainment. Mr. Sheen has developed a reputation as one of Hollywood’s most respected actors during a career that includes more than 60 film appearances.

In Focus Martin Sheen is looking at the innovations in healthcare that are making a difference in the lives of patients, and for the millions of Americans dealing with some form of mood disorder, new medications are helping people lead healthy, happy lives.

In this new report, In Focus will be talking to mental health experts about how these new medications work to achieve the right chemistry in the brain to help people overcome mood disorders. Coupled with therapy, these medications are helping people live lives free from the suffering of many serious conditions like depression or bipolar disorder.

The producers of In Focus with Martin Sheen are hoping to debut the new report in May. Viewers can find air times and dates by checking their local listings. For more information about the reports or to offer other ideas related to this topic, In Focus with Martin Sheen can be reached through the show’s official website at infocusptv.com or on Facebook at facebook.com/InFocusMartinSheen.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10521984.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
2. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
3. Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
4. Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities
5. Vermillion Sharpens Focus and Streamlines Operations in 2012
6. Inverseon Focuses on Mucous and Smoking Cessation
7. First Statewide Biotech Meeting Focuses on Patient Access, Innovation
8. Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
9. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
10. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
11. All the colors of a high-energy rainbow, in a tightly focused beam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... , ... May 23, 2017 , ... Federal funding for ... as an enabler of life-saving medical and other vital technologies — deserves continued support, ... joined others in the scientific community today in responding to the President’s budget request ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... cardiovascular cells for research and the development of cardiac regeneration therapies. The ... large numbers of cardiomyocytes (hPSC-CMs). Due to varying differentiation efficiencies, further enrichment ...
(Date:5/23/2017)... ... May 23, 2017 , ... Energetiq Technology, a ... a facility expansion to accommodate its rapid growth. , The renovations at the ... renovation of the existing areas. The expansion includes, a state-of-the-art engineering facility, and ...
(Date:5/22/2017)... , ... May 22, 2017 , ... Stratevi, a boutique ... to the East Coast. It has opened an office in downtown Boston at 745 ... finding it increasingly more important to generate evidence on the value they provide, not ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
Breaking Biology News(10 mins):